Founder of 5 different companies, including: Coty, Inc., Delete Blood Cancer and DKMS gemeinnützige GmbH, Peter Harf is a German entrepreneur and businessperson who has been the head of 21 different companies and presently occupies the position of Chairman & Chief Executive Officer of Joh. A. Benckiser GmbH, Managing Director at Lucresca SE, Managing Director at Agnaten SE, Chairman of Bally UK Sales Ltd., Chairman & Managing Partner at JAB Holding Co. SARL, Chairman & Chief Executive Officer of Coty, Inc. (which he founded in 1996), Chairman at Coty Italia SRL, Chairman & Managing Partner at JAB Holding Co. LLC, Chief Executive Officer for Parentes SE, Chairman-Management Board at JAB Luxury GmbH and Chief Executive Officer of Donata Holding SE (which are all subsidiaries of Agnaten SE) and Chairman for Bally International AG. Dr. Harf is also Executive Chairman for Delete Blood Cancer (he founded the company) and Chairman for Deutsche Stiftung Leben Spenden (he founded the company in 1997) and on the board of 12 other companies.
In his past career Peter Harf held the position of Chairman at Anheuser-Busch InBev SA, Principal at The Boston Consulting Group, Inc., Chairman for Espresso House Holding AB, Chairman for Belstaff Group SA, Non-Executive Chairman for Jimmy Choo Group Ltd., Chairman at Espresso House Sweden AB, Chief Executive Officer for JAB Holdings II BV, Senior Vice President-Corporate Planning at AEG AG and Executive Chairman for DKMS gemeinnützige GmbH (he founded the company in 2004).
He received a doctorate from Universität zu Köln and an MBA from Harvard Business School.